MDS
Completed
2,115 enrolled
REBOUND
Completed
126 enrolled
Treatment Patterns and Outcomes Among Patients With Chronic Myeloid Leukemia (CML) in All Lines of Treatment
Completed
2,298 enrolled
MPN-COVID
Completed
552 enrolled
KID-Tryp
Completed
402 enrolled
A Real-world Study About the Impact of Adverse Events (AEs) on Treatment Adjustments, Healthcare Resource Use, and Costs Among Chronic Myeloid Leukemia Patients
Completed
2,546 enrolled
Establishment of a Strategy for Preventing Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation by Exploring Immune Mechanisms of Regulatory and Effector T Cells
Completed
146 enrolled
A Study of Real-world Treatment and Burden of Chronic Myeloid Leukemia Patients in Japan
Completed
754 enrolled
BabyDetect
Completed
6,824 enrolled
MASCOT-R
Completed
238 enrolled
MonSThr
Completed
68 enrolled
Retro-prospective Observational Study on Risk of Progression in CP-CML Patients Eligible for TKI Discontinuation
Completed
260 enrolled
TIKlet
Completed
412 enrolled
Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study
Completed
100 enrolled
CAP
Completed
65 enrolled
CML0912
Completed
129 enrolled
RevlimidPMS
Completed
28 enrolled
Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies
Completed
81 enrolled
SYTHROM
Completed
253 enrolled
GITMO AML/MDS-Relapse Registry Study
Completed
859 enrolled
Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey
Completed
51 enrolled 8 charts
ROOT
Completed
167 enrolled
ABL-2022-03
Completed
2,043 enrolled
PANAM
Completed
170 enrolled
Evaluation of IFNγ and Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis
Completed
40 enrolled 43 charts
PV-ARC
Completed
1,150 enrolled
PAVE
Completed
467 enrolled
BLF
Completed
702 enrolled
Ultrasound Examination for Spleen Volume Evaluation in Myeloproliferative Neoplasms
Completed
45 enrolled
Population Pharmacokinetic Study Based on Quantitative Pharmacology in Patients With Lenalidomide
Completed
38 enrolled
SARS-CoV-2 Donor-Recipient Immunity Transfer
Completed
26 enrolled
Special Drug Use-results Surveillance of Scemblix Tablets
Completed
550 enrolled
Registry on Hypomethylating Agents in Myeloid Neoplasms
Completed
1,500 enrolled
Effect of 2nd Gen TKI in CML
Completed
432 enrolled
KIWIS
Completed
50 enrolled
EMATO0113
Completed
141 enrolled
Immunologic Response After Pandemic Influenza A (H1N1) Vaccine in Onco- Hematologic Patients
Completed
124 enrolled
MOSAICC
Completed
234 enrolled 7 charts
METER
Completed
998 enrolled
PREVALENCE STUDY OF PNH CLONES IN PATIENTS WITH NEOPLASIES
Completed
300 enrolled
Real-World Usage of Asciminib Among Patients With Chronic Myeloid Leukemia in Chronic Phase in the United States Using a Large Claims Database
Completed
425 enrolled
Early Detection of Epstein-Barr Virus Related Disease.
Completed
1,527 enrolled
Effect of Pharmacogenetics on Imatinib Plasma Level and Response
Completed
60 enrolled
Study to Evaluate Chronic Myeloid Leukemia Treatment Landscape and Real-life Treatment Outcomes in Hungary: Analysis of National Health Insurance Fund Database
Completed
1,484 enrolled 6 charts
A Study To Describe The Real World Use Of Bosutinib In The UK And Netherlands
Completed
87 enrolled 22 charts
Chemobrain
Completed
45 enrolled 10 charts
Observational Study on CML Patients in Any Phase of the Disease Treated With Ponatinib (Iclusig®)
Completed
120 enrolled
Comorbidity Burden and Use of Concomitant Medications at CML Diagnosis
Completed
527 enrolled
NOFRETETE
Completed
222 enrolled
Real-World Disease Management and Outcomes in Chronic Myeloid Leukaemia
Completed
555 enrolled